Company Fountain Biopharma Inc

Equities

4159

TW0004159009

Biotechnology & Medical Research

Business Summary

Managers

Members of the board

Share class

Company contact information

Sector

Sector Other Biotechnology & Medical Research

End-of-day quote Taipei Exchange Other stock markets 03:30:00 12/08/2019 am IST			5-day change	1st Jan Change
16.75 ^TWD	-0.30%		-1.93%	-.--%

Fountain Biopharma Inc. is a Taiwan-based company principally engaged in the research, development and sales of antibody drugs. The Company's main products include an anti-allergy single-injection antibody, FB825-Anti-CmX; a single-injection antibody, FB704A-Anti-IL6; a biosimilar drug, FB317-Omalizumab, and a biosimilar drug, FB121-Ibalizumab. The Company has not generated any revenue for the past two years.

Managers	Title	Age	Since
Hui Fang Huang CEO	Chief Executive Officer	-	-
Wen Tzu Hsiao DFI	Director of Finance/CFO	-	13/16/13
Nien Yi Chen IRC	Investor Relations Contact	-	01/12/01
Hung Chou PRN	Corporate Officer/Principal	-	-
Shu Yue Chen AUD	Comptroller/Controller/Auditor	-	18/16/18

Members of the board	Title	Age	Since
Chun Hung Chen BRD	Director/Board Member	69	06/17/06
Yung Hung Chung BRD	Director/Board Member	-	06/17/06
Hui Fang Huang CEO	Chief Executive Officer	-	-
Kuo Chen Li BRD	Director/Board Member	-	11/13/11
Mei An Liu BRD	Director/Board Member	-	06/17/06
Hsuan Ta Liu BRD	Director/Board Member	-	11/13/11
Chi Chou Liao BRD	Director/Board Member	-	11/13/11
Hong Chiun Wang BRD	Director/Board Member	58	06/17/06
Nien Yi Chen IRC	Investor Relations Contact	-	01/12/01
Wen Liang Huang BRD	Director/Board Member	-	06/17/06

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	302,423,000	35,164,000 ( 11.63 %)	20,649,450 ( 6.828 %)	11.63 %

Fountain Biopharma, Inc.

19/F-1 3 Yuanqu Street

115 03, Taipei

http://www.fountainmab.com

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Other Biotechnology & Medical Research

	1st Jan change	Capi.
FOUNTAIN BIOPHARMA INC	-.--%	16Cr
MODERNA, INC.	+67.53%	6.39TCr
IQVIA HOLDINGS INC.	-0.77%	4.18TCr
LONZA GROUP AG	+45.66%	4.07TCr
CELLTRION, INC.	-10.72%	2.71TCr
ICON PUBLIC LIMITED COMPANY	+13.30%	2.65TCr
ALNYLAM PHARMACEUTICALS, INC.	-22.79%	1.87TCr
BIO-TECHNE CORPORATION	+4.70%	1.27TCr
UNITED THERAPEUTICS CORPORATION	+24.10%	1.21TCr
MEDPACE HOLDINGS, INC.	+27.41%	1.21TCr

Other Biotechnology & Medical Research